May 28, 2026 04:00PM
May 28, 2026 04:00PM
May 13, 2026 04:43PM
Apr 23, 2026 04:05PM
Apr 23, 2026 04:05PM
Apr 22, 2026 08:30AM
Apr 22, 2026 08:30AM Outlook Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Mar 25, 2026 04:05PM
Mar 25, 2026 04:05PM
Mar 24, 2026 07:00AM
Mar 24, 2026 07:00AM
Mar 23, 2026 05:30PM
Mar 23, 2026 05:30PM
May 23, 2025 06:39AM Outlook Therapeutics (OTLK) Announces Pricing of $13.0 Million Public Offering
May 23, 2025 06:30AM
May 22, 2025 04:05PM
May 22, 2025 04:01PM
Mar 20, 2025 05:01PM
Feb 28, 2025 04:37PM
Jan 16, 2025 06:01AM
Jan 16, 2025 06:00AM Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial
Apr 26, 2024 04:19PM
Mar 28, 2024 05:04PM
Mar 25, 2024 04:12PM
Aug 14, 2023 05:23PM
Dec 29, 2022 09:07AM
Dec 23, 2022 06:01AM
Dec 23, 2022 06:00AM Outlook Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Nov 29, 2021 04:15PM
Nov 24, 2021 05:38AM
Nov 23, 2021 10:30PM
Nov 23, 2021 04:31PM
Nov 23, 2021 04:30PM
Mar 26, 2021 04:44PM
Feb 2, 2021 04:05PM Outlook Therapeutics Announces Closing of $35.0 Million Bought Deal
Jan 28, 2021 11:59PM
Jan 28, 2021 05:35PM
Jan 28, 2021 05:35PM
Jun 25, 2020 08:05AM
Jun 23, 2020 08:02AM
Jun 23, 2020 08:00AM
Feb 26, 2020 02:25PM Outlook Therapeutics Announces Closing of $10.2 Million Financings Priced At-The-Market
Feb 24, 2020 08:00AM
Jun 3, 2019 05:19PM

71,086 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All